시장보고서

상품코드

2089896

MRI 조영제 시장 규모 및 예측(2021-2034년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 : 유형, 투여 경로, 용도, 적응증, 최종사용자, 지역별

MRI Contrast Media Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Application, Indication, End User, and Geography

발행일: 2026년 06월 | 리서치사: 구분자

The Insight Partners | 페이지 정보: 영문 432 Pages | 배송안내 : 즉시배송

가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,398,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,273,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 12,149,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당사의 새로운 조사 리포트 'MRI 조영제 시장 예측(-2034년) - 세계 시장 분석 - 유형, 투여 경로, 용도, 적응증, 최종사용자, 지역별'에 따르면 이 시장은 2025년 5억 7,803만 달러에서 성장하며, 2034년에는 11억 6,391만 달러에 달할 것으로 예측됩니다. 2026-2034년에 CAGR 8.1%를 기록할 것으로 전망되고 있습니다. MRI 조영제 시장의 성장은 자기공명 관절조영술(MRA)을 통한 직접적인 관절내 조영을 통해 관절 질환의 진단 정확도가 향상되고, 조영제를 이용한 자기공명 림프관조영술(MRL)을 통해 림프계 질환을 비침습적으로 시각화 및 매핑할 수 있게된 점, 그리고 자기공명 담관·췌관 조영술(MRCP)에서 간담도계 조영제를 이용한 담도계 및 췌장계의 기능적·해부학적 평가에 기인합니다.

MRI 조영제 시장이란 신경계, 근골격계, 심혈관계, 림프계, 복부계 등의 질환 검출에 중점을 두고, 영상 해상도를 향상시켜 진단 정확도가 높은 영상을 얻기 위한 조영제의 개발 및 활용을 의미합니다.

북미의 MRI 조영제 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미는 MRI 조영제 시장을 주도하고 있으며, 가돌리늄계 조영제(GBCA)의 적응증 외 사용인 관절내 투여가 시장을 형성하고 있습니다. 기존의 MRI 검사와 비교했을 때, MRA는 관절순 파열, 연골 결손, 인대 손상의 진단에 있으며, 더 높은 정확도를 제공합니다. 이는 특히 어깨, 고관절, 무릎에서 두드러집니다. MRA는 스포츠 의학 및 정형외과 분야에서도 널리 활용되고 있으며, 골격방사선학회(Society of Skeletal Radiology)는 기존의 MRI 영상만으로는 진단을 확정할 수 없는 경우, 직접 MRA를 시행할 것을 권장하고 있습니다. GBCA의 최적 희석 농도는 일반적으로 1.25-2.5 mmol/L(용액 중 용매 1리터당 용질의 몰수) 범위이며, 이 희석 농도를 통해 안전성과 영상 품질의 균형이 적절하게 유지됩니다. 일부 의료기관에서는 1.5T 조영 MRI 대신 고해상도 3T 비조영 MRI를 도입하기 시작했습니다. 그러나 더 낮은 자기장을 사용하는 MRI 시스템을 도입한 의료기관에서는 MRA가 여전히 필요로 하고 있습니다.

일부 클리닉에서는 림프계의 상세한 영상을 촬영하여 림프정맥 문합술 등의 수술 계획 및 평가를 지원하기 위해, 가돌리늄 및 산화철계 조영제를 이용한 MRL이 더욱 널리 활용되고 있습니다. 또한 조영 MRCP에서는 간담도계 조영제(예: 가독세테이트 나트륨)를 사용하여 간담도계를 종합적으로 평가하며, 장기 기증자의 수술 전 평가 과정의 일환으로 시행되고 있습니다. 북미의 첨단인 의료 시스템과 대환상 GBCA 사용이 비교적 선호되는 경향은, 최신 프로토콜이 지속적으로 개발되는 가운데 안전하고 표준화된 고품질 영상 진단 서비스를 제공하는 검사 기법을 더욱 발전시키기 위한 기반이 되고 있습니다.

자기공명 림프관 조영술(MRL)에서 림프관 특이적 산화철 나노입자 및 하이브리드 프로토콜이 향후 시장 기회를 창출할 것으로 보인다

INV-001 및 페르모크시톨을 포함한 산화철 나노입자를 활용한 새로운 자기공명 림프관 조영술(MRL) 방법은 림프관 영상 분야의 새로운 방향성을 제시합니다. 이 두 조영제는 모두 가돌리늄을 사용하지 않으면서도 림프관 특이적 시각화를 가능하게 하며, 반복적인 영상 진단으로 인한 잠재적 부작용에 대한 대안이 되고, 정맥 신호에 의한 간섭을 최소화합니다. INV-001은 입자 크기가 최적화되어 있으며, 조영제가 림프관에 우선적으로 축적됨으로써 림프 해부 구조에 대한 고품질의 3D 영상을 제공합니다. 이를 통해 진피에서의 역류, 폐색 및 우회 혈관을 확인할 수 있습니다. 또한 INV-001은 림프부종의 중증도 평가(임상적) 및 정량적(바이오마커) 평가 모두와 강한 상관관계를 보이며, 체외로 신속하게 배출됩니다. 피내 투여와 정맥내 투여의 페르모시톨을 결합한 하이브리드 MRL 기술(즉, 듀얼 에이전트 이완 조영법(DARC-MRL) 및 ION-MRL)을 통해 정맥 신호의 억제 능력이 향상되어, 말초 림프계 및 흉관을 포함한 중추 림프계의 가시성이 향상됩니다. 또한 페르모시톨은 전이성 림프절의 검출에 있으며, 높은 민감도를 보입니다. 향후 방향성으로는 프로토콜의 표준화, 저침습 시술과의 통합, 그리고 소아 분야로의 확대가 꼽힙니다. 이러한 발전으로 인해 수술 계획의 정확도가 향상되고, 치료 경과를 모니터링할 수 있게 되며, 기존의 림프 신티그래피를 대체할 수 있는 방사선 피폭이 없는 안전한 대안이 실현될 것입니다.

According to our new research study on "MRI Contrast Media Market Forecast to 2034 -Global Analysis - by Type, Route of Administration, Application, Indication, End user, and Geography," the market is anticipated to grow from US$ 578.03 million in 2025 and is projected to reach US$ 1,163.91 million by 2034; it is expected to register a CAGR of 8.1% during 2026-2034. The MRI contrast media market growth is attributed to enhanced diagnostic precision in joint pathologies through direct intra-articular contrast in magnetic resonance arthrography (MRA), noninvasive visualization and mapping of lymphatic disorders via contrast-enhanced magnetic resonance lymphangiography (MRL), and functional and anatomical evaluation of biliary and pancreatic systems with hepatobiliary contrast agents in magnetic resonance cholangiopancreatography (MRCP).

The MRI contrast media market refers to the development and utilization of contrast agents that improve image resolution and enhance diagnostically accurate images, focusing on disease detection, including neurological, musculoskeletal, cardiovascular, lymphatic, and abdominal systems.

The MRI contrast media market in North America is segmented into the US, Canada, and Mexico. North America is leading the MRI contrast media market, shaped by off-label intra-articular administration of gadolinium-based contrast agents (GBCAs). When compared to traditional MRI methods, MRA offers a greater level of diagnostic accuracy in detecting labral tears, cartilage defects, and ligament injuries. This is particularly the case in the shoulder, hip, and knee. MRA is also commonly used in the fields of sports medicine and orthopedics; the Society of Skeletal Radiology suggests using direct MRA when conventional MRI imaging is inconclusive. The optimal dilution levels of GBCA generally fall between 1.25-2.5 mmol/L (mol of solute per litre of solvent in solution); this dilution provides a good compromise between safety and image quality. Some facilities have begun to adopt high-resolution 3T non-contrast MRIs in lieu of using 1.5T contrast-enhanced MRIs. However, MRA is still considered necessary in facilities that utilize lower strength MRI systems.

MRL is becoming more widely used in select clinics, employing gadolinium and iron oxide-based contrast agents for the purpose of creating detailed images of the lymphatic system and assisting with surgical planning and evaluation for procedures such as lymphovenous anastomosis. In addition, contrast-enhanced MRCP uses hepatobiliary contrast agents (e.g., gadoxetate disodium) to provide a comprehensive evaluation of the biliary tree and does so as part of a preoperative assessment process for organ donors. The advanced healthcare systems in North America and the relative preference for the use of macrocyclic GBCAs provide a foundation for further developing the methodology of providing safe, standardized, high-quality imaging services as current updated protocols continue to be developed.

Lymphatic-Specific Iron Oxide Nanoparticles and Hybrid Protocols in Magnetic Resonance Lymphangiography (MRL) to Provide Market Opportunities in Future

New Magnetic Resonance Lymphangiography (MRL) methods utilizing iron oxide nanoparticles including INV-001 and ferumoxytol, are the new direction in Lymphatic Imaging. Both of these agents allow for lymphatic-specific visualization without the use of gadolinium, providing an alternative to the potential adverse effects from repeated imaging and minimizing contaminating venous signal. INV-001 has been designed with an optimized particle size allowing the preferential accumulation of the agent in lymphatic vessels to provide high quality 3D images of lymphatic anatomy, which will permit the identification of dermal backflow, obstruction and collateral vessels. INV-001 has also demonstrated strong correlation to both lymphedema severity assessments (clinical) and quantitative (biomarker) assessment of lymphedema, whilst being rapidly cleared from the body. Hybrid MRL techniques to combine intradermal with intravenous ferumoxytol (i.e. Dual Agent Relaxation Contrast (DARC-MRL) and ION-MRL) will enable improved ability to suppress venous signals to enhance visualization of both the peripheral lymphatic system and the central lymphatic system which will include the thoracic duct. Ferumoxytol also provides high sensitivity for the detection of metastatic lymph nodes. Future directions involve protocol standardization, integration with minimally invasive procedures and expansion into pediatrics. Improved surgical planning, monitoring of treatment progress, and safe radiation-free alternatives to traditional lymphoscintigraphy will result from these developments.

The Food and Drug Administration (FDA), Medicines and Healthcare products Regulatory Agency, European Medicines Agency, Pharmaceuticals and Medical Devices Agency, Investor Presentation are among the primary and secondary sources referred to while preparing the MRI contrast media market report.

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. MRI Contrast Media Market Landscape

2.1 Overview
2.2 Value Chain Analysis
- 2.2.1 Raw Materials / Components
- 2.2.2 Manufacturing Process / Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End User
- 2.2.5 Level of Integration
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Force Analysis
- 2.4.1 Threat of New Entrants (Moderate to Low)
- 2.4.2 Bargaining Power of Suppliers (Low to Moderate)
- 2.4.3 Bargaining Power of Buyers (High)
- 2.4.4 Threat of Substitutes (Moderate and Rising)
- 2.4.5 Competitive Rivalry (High)
2.5 PEST Analysis
2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
- 2.6.1 Import-Export Analysis for Key Countries (30063000)
2.7 Impact of Artificial Intelligence (AI)
2.8 Product or Technology Roadmap
2.9 Sustainability and ESG Trends
- 2.9.1 Environmental Trends
- 2.9.2 Social Trends
- 2.9.3 Governance Trends
2.10 Patent Analysis
2.11 Regulatory Framework
2.12 Regional Average Selling Prices (ASP) of Product Categories, 2025

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. MRI Contrast Media Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Enhanced Diagnostic Precision in Joint Pathologies through Direct Intra-Articular Contrast in Magnetic Resonance Arthrography (MRA)
- 4.1.2 Noninvasive Visualization and Mapping of Lymphatic Disorders via Contrast-Enhanced Magnetic Resonance Lymphangiography (MRL)
- 4.1.3 Functional and Anatomical Evaluation of Biliary and Pancreatic Systems with Hepatobiliary Contrast Agents in Magnetic Resonance Cholangiopancreatography (MRCP)
4.2 Market Restraints
- 4.2.1 Safety Concerns and Potential Chondrotoxicity Associated with Intra-Articular Gadolinium Use in Magnetic Resonance Arthrography (MRA)
- 4.2.2 Technical Limitations, Venous Contamination, and Procedural Discomfort in Contrast-Enhanced Magnetic Resonance Lymphangiography (MRL)
- 4.2.3 Risks of Gadolinium Retention, Renal Impairment Screening, and Functional Limitations in Hepatobiliary Contrast-Enhanced Magnetic Resonance Cholangiopancreatography (MRCP)
4.3 Market Opportunities
- 4.3.1 Development and Adoption of High-Relaxivity or Alternative Contrast Agents for Safer, Dose-Reduced Magnetic Resonance Arthrography (MRA)
- 4.3.2 Innovation in Lymphatic-Specific Contrast Techniques and Hybrid Protocols for Advanced Magnetic Resonance Lymphangiography (MRL)
- 4.3.3 Expansion of Functional Hepatobiliary Phase Imaging with Specialized Agents in Magnetic Resonance Cholangiopancreatography (MRCP)
4.4 Future Trends
- 4.4.1 Shift Toward Gadolinium-Free Iron-Based and High-Relaxivity Alternatives in Magnetic Resonance Arthrography (MRA)
- 4.4.2 Lymphatic-Specific Iron Oxide Nanoparticles and Hybrid Protocols in Magnetic Resonance Lymphangiography (MRL)
- 4.4.3 Integration of AI, Radiomics, and Functional Biomarkers with Hepatobiliary Agents in Magnetic Resonance Cholangiopancreatography (MRCP)
4.5 Impact of Drivers and Restraints

5. MRI Contrast Media Market - Global Market Analysis

5.1 MRI Contrast Media Market Revenue (US$ Thousand), 2021-2034
5.2 MRI Contrast Media Market Forecast and Analysis

6. MRI Contrast Media Market Revenue Analysis - Type

6.1 MRI Contrast Media Market Forecasts and Analysis by Type
- 6.1.1 Paramagnetic
  - 6.1.1.1 Overview
  - 6.1.1.2 Paramagnetic: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 6.1.2 Super Paramagnetic
  - 6.1.2.1 Overview
  - 6.1.2.2 Super Paramagnetic: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)

7. MRI Contrast Media Market Revenue Analysis - Route Of Administration

7.1 MRI Contrast Media Market Forecasts and Analysis by Route Of Administration
- 7.1.1 Intra-articular
  - 7.1.1.1 Overview
  - 7.1.1.2 Intra-articular: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 7.1.2 Oral and IV
  - 7.1.2.1 Overview
  - 7.1.2.2 Oral and IV: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 7.1.3 Others
  - 7.1.3.1 Overview
  - 7.1.3.2 Others: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)

8. MRI Contrast Media Market Revenue Analysis - Application

8.1 MRI Contrast Media Market Forecasts and Analysis by Application
- 8.1.1 Magnetic Resonance Arthrography (MRA)
  - 8.1.1.1 Overview
  - 8.1.1.2 Magnetic Resonance Arthrography (MRA): MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 8.1.2 Magnetic Resonance Cholangiopancreatography (MRCP)
  - 8.1.2.1 Overview
  - 8.1.2.2 Magnetic Resonance Cholangiopancreatography (MRCP): MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 8.1.3 Magnetic Resonance Lymphangiography (MRL)
  - 8.1.3.1 Overview
  - 8.1.3.2 Magnetic Resonance Lymphangiography (MRL): MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)

9. MRI Contrast Media Market Revenue Analysis - Indication

9.1 MRI Contrast Media Market Forecasts and Analysis by Indication
- 9.1.1 Magnetic Resonance Arthrography
  - 9.1.1.1 Overview
  - 9.1.1.2 Magnetic Resonance Arthrography: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 9.1.2 Magnetic Resonance Cholangiopancreatography
  - 9.1.2.1 Overview
  - 9.1.2.2 Magnetic Resonance Cholangiopancreatography: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 9.1.3 Magnetic Resonance Lymphangiography
  - 9.1.3.1 Overview
  - 9.1.3.2 Magnetic Resonance Lymphangiography: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)

10. MRI Contrast Media Market Revenue Analysis - End User

10.1 MRI Contrast Media Market Forecasts and Analysis by End User
- 10.1.1 Hospital and Clinics
  - 10.1.1.1 Overview
  - 10.1.1.2 Hospital and Clinics: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 10.1.2 Diagnostic and Imaging Centers
  - 10.1.2.1 Overview
  - 10.1.2.2 Diagnostic and Imaging Centers: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 10.1.3 Research Institutes
  - 10.1.3.1 Overview
  - 10.1.3.2 Research Institutes: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)
- 10.1.4 Others
  - 10.1.4.1 Overview
  - 10.1.4.2 Others: MRI Contrast Media Market - Revenue, 2021-2034 (US$ Thousand)

11. MRI Contrast Media Market - Geographical Analysis

11.1 North America
- 11.1.1 North America MRI Contrast Media Market Overview
- 11.1.2 North America: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 11.1.3 North America: MRI Contrast Media Market - By Segmentation
  - 11.1.3.1 Type
    - 11.1.3.1.1 Paramagnetic
    - 11.1.3.1.2 Super Paramagnetic
  - 11.1.3.2 Route Of Administration
  - 11.1.3.3 Application
    - 11.1.3.3.1 Magnetic Resonance Arthrography (MRA)
      - 11.1.3.3.1.1 Shoulder
    - 11.1.3.3.2 Magnetic Resonance Lymphangiography (MRL)
  - 11.1.3.4 Indication
    - 11.1.3.4.1 Magnetic Resonance Arthrography
    - 11.1.3.4.2 Magnetic Resonance Lymphangiography
    - 11.1.3.4.3 Magnetic Resonance Cholangiopancreatography
  - 11.1.3.5 End User
- 11.1.4 North America: MRI Contrast Media Market Breakdown by Countries
  - 11.1.4.1 United States Market
    - 11.1.4.1.1 United States: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.1.4.1.2 United States: MRI Contrast Media Market - By Segmentation
      - 11.1.4.1.2.1 Type
        
        11.1.4.1.2.1.1 Paramagnetic
        11.1.4.1.2.1.2 Super Paramagnetic
      - 11.1.4.1.2.2 Route Of Administration
      - 11.1.4.1.2.3 Application
        
        11.1.4.1.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.1.4.1.2.3.1.1 Shoulder
        11.1.4.1.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.1.4.1.2.4 Indication
        
        11.1.4.1.2.4.1 Magnetic Resonance Arthrography
        11.1.4.1.2.4.2 Magnetic Resonance Lymphangiography
        11.1.4.1.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.1.4.1.2.5 End User
  - 11.1.4.2 Canada Market
    - 11.1.4.2.1 Canada: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.1.4.2.2 Canada: MRI Contrast Media Market - By Segmentation
      - 11.1.4.2.2.1 Type
        
        11.1.4.2.2.1.1 Paramagnetic
        11.1.4.2.2.1.2 Super Paramagnetic
      - 11.1.4.2.2.2 Route Of Administration
      - 11.1.4.2.2.3 Application
        
        11.1.4.2.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.1.4.2.2.3.1.1 Shoulder
        11.1.4.2.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.1.4.2.2.4 Indication
        
        11.1.4.2.2.4.1 Magnetic Resonance Arthrography
        11.1.4.2.2.4.2 Magnetic Resonance Lymphangiography
        11.1.4.2.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.1.4.2.2.5 End User
  - 11.1.4.3 Mexico Market
    - 11.1.4.3.1 Mexico: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.1.4.3.2 Mexico: MRI Contrast Media Market - By Segmentation
      - 11.1.4.3.2.1 Type
        
        11.1.4.3.2.1.1 Paramagnetic
        11.1.4.3.2.1.2 Super Paramagnetic
      - 11.1.4.3.2.2 Route Of Administration
      - 11.1.4.3.2.3 Application
        
        11.1.4.3.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.1.4.3.2.3.1.1 Shoulder
        11.1.4.3.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.1.4.3.2.4 Indication
        
        11.1.4.3.2.4.1 Magnetic Resonance Arthrography
        11.1.4.3.2.4.2 Magnetic Resonance Lymphangiography
        11.1.4.3.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.1.4.3.2.5 End User
11.2 Europe
- 11.2.1 Europe MRI Contrast Media Market Overview
- 11.2.2 Europe: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 11.2.3 Europe: MRI Contrast Media Market - By Segmentation
  - 11.2.3.1 Type
    - 11.2.3.1.1 Paramagnetic
    - 11.2.3.1.2 Super Paramagnetic
  - 11.2.3.2 Route Of Administration
  - 11.2.3.3 Application
    - 11.2.3.3.1 Magnetic Resonance Arthrography (MRA)
      - 11.2.3.3.1.1 Shoulder
    - 11.2.3.3.2 Magnetic Resonance Lymphangiography (MRL)
  - 11.2.3.4 Indication
    - 11.2.3.4.1 Magnetic Resonance Arthrography
    - 11.2.3.4.2 Magnetic Resonance Lymphangiography
    - 11.2.3.4.3 Magnetic Resonance Cholangiopancreatography
  - 11.2.3.5 End User
- 11.2.4 Europe: MRI Contrast Media Market Breakdown by Countries
  - 11.2.4.1 Germany Market
    - 11.2.4.1.1 Germany: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.2.4.1.2 Germany: MRI Contrast Media Market - By Segmentation
      - 11.2.4.1.2.1 Type
        
        11.2.4.1.2.1.1 Paramagnetic
        11.2.4.1.2.1.2 Super Paramagnetic
      - 11.2.4.1.2.2 Route Of Administration
      - 11.2.4.1.2.3 Application
        
        11.2.4.1.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.2.4.1.2.3.1.1 Shoulder
        11.2.4.1.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.2.4.1.2.4 Indication
        
        11.2.4.1.2.4.1 Magnetic Resonance Arthrography
        11.2.4.1.2.4.2 Magnetic Resonance Lymphangiography
        11.2.4.1.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.2.4.1.2.5 End User
  - 11.2.4.2 United Kingdom Market
    - 11.2.4.2.1 United Kingdom: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.2.4.2.2 United Kingdom: MRI Contrast Media Market - By Segmentation
      - 11.2.4.2.2.1 Type
        
        11.2.4.2.2.1.1 Paramagnetic
        11.2.4.2.2.1.2 Super Paramagnetic
      - 11.2.4.2.2.2 Route Of Administration
      - 11.2.4.2.2.3 Application
        
        11.2.4.2.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.2.4.2.2.3.1.1 Shoulder
        11.2.4.2.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.2.4.2.2.4 Indication
        
        11.2.4.2.2.4.1 Magnetic Resonance Arthrography
        11.2.4.2.2.4.2 Magnetic Resonance Lymphangiography
        11.2.4.2.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.2.4.2.2.5 End User
  - 11.2.4.3 France Market
    - 11.2.4.3.1 France: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.2.4.3.2 France: MRI Contrast Media Market - By Segmentation
      - 11.2.4.3.2.1 Type
        
        11.2.4.3.2.1.1 Paramagnetic
        11.2.4.3.2.1.2 Super Paramagnetic
      - 11.2.4.3.2.2 Route Of Administration
      - 11.2.4.3.2.3 Application
        
        11.2.4.3.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.2.4.3.2.3.1.1 Shoulder
        11.2.4.3.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.2.4.3.2.4 Indication
        
        11.2.4.3.2.4.1 Magnetic Resonance Arthrography
        11.2.4.3.2.4.2 Magnetic Resonance Lymphangiography
        11.2.4.3.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.2.4.3.2.5 End User
  - 11.2.4.4 Italy Market
    - 11.2.4.4.1 Italy: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.2.4.4.2 Italy: MRI Contrast Media Market - By Segmentation
      - 11.2.4.4.2.1 Type
        
        11.2.4.4.2.1.1 Paramagnetic
        11.2.4.4.2.1.2 Super Paramagnetic
      - 11.2.4.4.2.2 Route Of Administration
      - 11.2.4.4.2.3 Application
        
        11.2.4.4.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.2.4.4.2.3.1.1 Shoulder
        11.2.4.4.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.2.4.4.2.4 Indication
        
        11.2.4.4.2.4.1 Magnetic Resonance Arthrography
        11.2.4.4.2.4.2 Magnetic Resonance Lymphangiography
        11.2.4.4.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.2.4.4.2.5 End User
  - 11.2.4.5 Spain Market
    - 11.2.4.5.1 Spain: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.2.4.5.2 Spain: MRI Contrast Media Market - By Segmentation
      - 11.2.4.5.2.1 Type
        
        11.2.4.5.2.1.1 Paramagnetic
        11.2.4.5.2.1.2 Super Paramagnetic
      - 11.2.4.5.2.2 Route Of Administration
      - 11.2.4.5.2.3 Application
        
        11.2.4.5.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.2.4.5.2.3.1.1 Shoulder
        11.2.4.5.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.2.4.5.2.4 Indication
        
        11.2.4.5.2.4.1 Magnetic Resonance Arthrography
        11.2.4.5.2.4.2 Magnetic Resonance Lymphangiography
        11.2.4.5.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.2.4.5.2.5 End User
  - 11.2.4.6 Rest of Europe Market
    - 11.2.4.6.1 Rest of Europe: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.2.4.6.2 Rest of Europe: MRI Contrast Media Market - By Segmentation
      - 11.2.4.6.2.1 Type
        
        11.2.4.6.2.1.1 Paramagnetic
        11.2.4.6.2.1.2 Super Paramagnetic
      - 11.2.4.6.2.2 Route Of Administration
      - 11.2.4.6.2.3 Application
        
        11.2.4.6.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.2.4.6.2.3.1.1 Shoulder
        11.2.4.6.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.2.4.6.2.4 Indication
        
        11.2.4.6.2.4.1 Magnetic Resonance Arthrography
        11.2.4.6.2.4.2 Magnetic Resonance Lymphangiography
        11.2.4.6.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.2.4.6.2.5 End User
11.3 Asia Pacific
- 11.3.1 Asia Pacific MRI Contrast Media Market Overview
- 11.3.2 Asia Pacific: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 11.3.3 Asia Pacific: MRI Contrast Media Market - By Segmentation
  - 11.3.3.1 Type
    - 11.3.3.1.1 Paramagnetic
    - 11.3.3.1.2 Super Paramagnetic
  - 11.3.3.2 Route Of Administration
  - 11.3.3.3 Application
    - 11.3.3.3.1 Magnetic Resonance Arthrography (MRA)
      - 11.3.3.3.1.1 Shoulder
    - 11.3.3.3.2 Magnetic Resonance Lymphangiography (MRL)
  - 11.3.3.4 Indication
    - 11.3.3.4.1 Magnetic Resonance Arthrography
    - 11.3.3.4.2 Magnetic Resonance Lymphangiography
    - 11.3.3.4.3 Magnetic Resonance Cholangiopancreatography
  - 11.3.3.5 End User
- 11.3.4 Asia Pacific: MRI Contrast Media Market Breakdown by Countries
  - 11.3.4.1 China Market
    - 11.3.4.1.1 China: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.3.4.1.2 China: MRI Contrast Media Market - By Segmentation
      - 11.3.4.1.2.1 Type
        
        11.3.4.1.2.1.1 Paramagnetic
        11.3.4.1.2.1.2 Super Paramagnetic
      - 11.3.4.1.2.2 Route Of Administration
      - 11.3.4.1.2.3 Application
        
        11.3.4.1.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.3.4.1.2.3.1.1 Shoulder
        11.3.4.1.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.3.4.1.2.4 Indication
        
        11.3.4.1.2.4.1 Magnetic Resonance Arthrography
        11.3.4.1.2.4.2 Magnetic Resonance Lymphangiography
        11.3.4.1.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.3.4.1.2.5 End User
  - 11.3.4.2 Japan Market
    - 11.3.4.2.1 Japan: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.3.4.2.2 Japan: MRI Contrast Media Market - By Segmentation
      - 11.3.4.2.2.1 Type
        
        11.3.4.2.2.1.1 Paramagnetic
        11.3.4.2.2.1.2 Super Paramagnetic
      - 11.3.4.2.2.2 Route Of Administration
      - 11.3.4.2.2.3 Application
        
        11.3.4.2.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.3.4.2.2.3.1.1 Shoulder
        11.3.4.2.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.3.4.2.2.4 Indication
        
        11.3.4.2.2.4.1 Magnetic Resonance Arthrography
        11.3.4.2.2.4.2 Magnetic Resonance Lymphangiography
        11.3.4.2.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.3.4.2.2.5 End User
  - 11.3.4.3 India Market
    - 11.3.4.3.1 India: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.3.4.3.2 India: MRI Contrast Media Market - By Segmentation
      - 11.3.4.3.2.1 Type
        
        11.3.4.3.2.1.1 Paramagnetic
        11.3.4.3.2.1.2 Super Paramagnetic
      - 11.3.4.3.2.2 Route Of Administration
      - 11.3.4.3.2.3 Application
        
        11.3.4.3.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.3.4.3.2.3.1.1 Shoulder
        11.3.4.3.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.3.4.3.2.4 Indication
        
        11.3.4.3.2.4.1 Magnetic Resonance Arthrography
        11.3.4.3.2.4.2 Magnetic Resonance Lymphangiography
        11.3.4.3.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.3.4.3.2.5 End User
  - 11.3.4.4 Australia Market
    - 11.3.4.4.1 Australia: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.3.4.4.2 Australia: MRI Contrast Media Market - By Segmentation
      - 11.3.4.4.2.1 Type
        
        11.3.4.4.2.1.1 Paramagnetic
        11.3.4.4.2.1.2 Super Paramagnetic
      - 11.3.4.4.2.2 Route Of Administration
      - 11.3.4.4.2.3 Application
        
        11.3.4.4.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.3.4.4.2.3.1.1 Shoulder
        11.3.4.4.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.3.4.4.2.4 Indication
        
        11.3.4.4.2.4.1 Magnetic Resonance Arthrography
        11.3.4.4.2.4.2 Magnetic Resonance Lymphangiography
        11.3.4.4.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.3.4.4.2.5 End User
  - 11.3.4.5 Korea Market
    - 11.3.4.5.1 Korea: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.3.4.5.2 Korea: MRI Contrast Media Market - By Segmentation
      - 11.3.4.5.2.1 Type
        
        11.3.4.5.2.1.1 Paramagnetic
        11.3.4.5.2.1.2 Super Paramagnetic
      - 11.3.4.5.2.2 Route Of Administration
      - 11.3.4.5.2.3 Application
        
        11.3.4.5.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.3.4.5.2.3.1.1 Shoulder
        11.3.4.5.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.3.4.5.2.4 Indication
        
        11.3.4.5.2.4.1 Magnetic Resonance Arthrography
        11.3.4.5.2.4.2 Magnetic Resonance Lymphangiography
        11.3.4.5.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.3.4.5.2.5 End User
  - 11.3.4.6 Rest of Asia Pacific Market
    - 11.3.4.6.1 Rest of Asia Pacific: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
    - 11.3.4.6.2 Rest of Asia Pacific: MRI Contrast Media Market - By Segmentation
      - 11.3.4.6.2.1 Type
        
        11.3.4.6.2.1.1 Paramagnetic
        11.3.4.6.2.1.2 Super Paramagnetic
      - 11.3.4.6.2.2 Route Of Administration
      - 11.3.4.6.2.3 Application
        
        11.3.4.6.2.3.1 Magnetic Resonance Arthrography (MRA)
        11.3.4.6.2.3.1.1 Shoulder
        11.3.4.6.2.3.2 Magnetic Resonance Lymphangiography (MRL)
      - 11.3.4.6.2.4 Indication
        
        11.3.4.6.2.4.1 Magnetic Resonance Arthrography
        11.3.4.6.2.4.2 Magnetic Resonance Lymphangiography
        11.3.4.6.2.4.3 Magnetic Resonance Cholangiopancreatography
      - 11.3.4.6.2.5 End User
11.4 Rest of the World
- 11.4.1 Rest of the World MRI Contrast Media Market Overview
- 11.4.2 Rest of the World: MRI Contrast Media Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 11.4.3 Rest of the World: MRI Contrast Media Market - By Segmentation
  - 11.4.3.1 Type
    - 11.4.3.1.1 Paramagnetic
    - 11.4.3.1.2 Super Paramagnetic
  - 11.4.3.2 Route Of Administration
  - 11.4.3.3 Application
    - 11.4.3.3.1 Magnetic Resonance Arthrography (MRA)
      - 11.4.3.3.1.1 Shoulder
    - 11.4.3.3.2 Magnetic Resonance Lymphangiography (MRL)
  - 11.4.3.4 Indication
    - 11.4.3.4.1 Magnetic Resonance Arthrography
    - 11.4.3.4.2 Magnetic Resonance Lymphangiography
    - 11.4.3.4.3 Magnetic Resonance Cholangiopancreatography
  - 11.4.3.5 End User

12. MRI Contrast Media Market Industry Landscape

13. MRI Contrast Media Market - Key Company Profiles

13.1 GE HealthCare Technologies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bayer AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Bracco Imaging S.p.A
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Guerbet SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Beijing Beilu Pharmaceutical Co., Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 SANOCHEMIA Pharmazeutika GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Subhra Pharma Pvt Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 BioPAL, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 JB Pharma
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Azurity Pharmaceuticals, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 Glossary
14.2 Research Methodology and Approach
- 14.2.1 Secondary Research
- 14.2.2 Primary Research
- 14.2.3 Market Estimation Approach
  - 14.2.3.1 Supply Side Analysis
  - 14.2.3.2 Demand Side Analysis
- 14.2.4 Research Assumptions and Limitations
- 14.2.5 Currency Conversion
14.3 About The Insight Partners
14.4 Market Intelligence Cloud

MRI 조영제 시장 규모 및 예측(2021-2034년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 : 유형, 투여 경로, 용도, 적응증, 최종사용자, 지역별

MRI Contrast Media Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Application, Indication, End User, and Geography

목차

제1장 개요

제2장 MRI 조영제 시장 전망

제3장 경쟁 구도

제4장 MRI 조영제 시장 : 주요 업계 역학

제5장 MRI 조영제 시장 : 세계 시장 분석

제6장 MRI 조영제 시장 매출 분석 : 유형별

제7장 MRI 조영제 시장 매출 분석 : 투여 경로별

제8장 MRI 조영제 시장 매출 분석 : 용도별

제9장 MRI 조영제 시장 매출 분석 : 적응증별

제10장 MRI 조영제 시장 매출 분석 : 최종사용자별

제11장 MRI 조영제 시장 : 지역별 분석

제12장 MRI 조영제 시장 업계 상황

제13장 MRI 조영제 시장 : 주요 기업 개요

제14장 부록